Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 359.35 INR
Change Today +10.25 / 2.94%
Volume 30.7K
INDR On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 05/4/15 All times are local (Market data is delayed by at least 15 minutes).

indoco remedies ltd (INDR) Snapshot

Open
356.90
Previous Close
349.10
Day High
362.65
Day Low
351.00
52 Week High
04/6/15 - 401.00
52 Week Low
05/5/14 - 135.10
Market Cap
33.1B
Average Volume 10 Days
56.3K
EPS TTM
6.29
Shares Outstanding
92.2M
EX-Date
07/21/14
P/E TM
57.1x
Dividend
1.40
Dividend Yield
0.39%
Current Stock Chart for INDOCO REMEDIES LTD (INDR)

Related News

No related news articles were found.

indoco remedies ltd (INDR) Related Businessweek News

No Related Businessweek News Found

indoco remedies ltd (INDR) Details

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India and internationally. It provides anti-cold, anti-spasmodic, anti-infective, anti-inflammatory, stomatological, anti-fungal, cough and cold preparation, cardiovascular, multivitamin products, etc., as well as anti-bacterial, analgesic, anti-asthamic, anti-spasmodic products, etc. The company also provides anti-hypersensitive toothpaste, anti-septic gel, oral NSAID, antibacterial mouthwash and gel products, etc.; antibiotics and antiemetic products; ophthalmic and ENT products; and lipid lowering agents, antiulcerants, antispasmodics, nutrition and metabolism, diabetic neuropathic pain, steroid, anti-infective, and muscle relaxant products. In addition, it offers APIs in various therapeutic areas, such as antiurolithic, antidiabetic, antipsychotic, antiglaucoma, antihistaminic, antiinflammatory, antispasmodic, antilipemic, antiparkinsonian, and anticonvulsant. Further, the company provides contract research services comprising custom synthesis of molecules and intermediates; process chemistry research and development; non–infringing process designing and scale up; and analytical method development/validation, impurity profiling, and polymorphic studies, as well as contract manufacturing services. It serves general practitioners, consultant physicians, pediatricians, ENTs, cardiologists, diabetologists, endocrinologists, nephrologists, gynecologists, dentists, ophthalmologists, and orthopaedicians. The company, formerly known as Indo Continental Trading Company, was founded in 1945 and is based in Mumbai, India.

4,300 Employees
Last Reported Date: 07/4/13
Founded in 1945

indoco remedies ltd (INDR) Top Compensated Officers

Managing Director, Director of Human Resource...
Total Annual Compensation: 7.6M
Joint Managing Director, Executive Director, ...
Total Annual Compensation: 6.6M
Executive Chairman
Total Annual Compensation: 10.8M
Compensation as of Fiscal Year 2014.

indoco remedies ltd (INDR) Key Developments

Indoco Remedies Limited, Board Meeting, Mar 23, 2015

Indoco Remedies Limited, Board Meeting, Mar 23, 2015. Agenda: To review the performance of non-independent directors and the Board as a whole; to review the performance of the Chairperson of the company, taking into account the views of executive directors and non-executive directors; and to assess the quality, quantity and timeliness of flow of information between the company management and the Board that is necessary for the Board to effectively and reasonably perform their duties.

Indoco Remedies Announces Earnings Results for the Third Quarter 2015

Indoco Remedies announced earnings results for the third quarter 2015. For the quarter, the company reported a 53% growth in profit after tax was INR 216 million compared to INR 141 million in the corresponding quarter last year. Net Revenue was grew by 13% to INR 2,129 million as against INR 1,884 million for the same period last year. Earnings per share in October 2014 to December 2014 rose to INR 2.35 from INR 1.53 in the same quarter last year.

Indoco Remedies Limited, Q3 2015 Earnings Call, Jan 30, 2015

Indoco Remedies Limited, Q3 2015 Earnings Call, Jan 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INDR:IN 359.35 INR +10.25

INDR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajanta Pharma Ltd 1,327 INR +63.70
Unichem Laboratories Ltd 205.55 INR +1.05
View Industry Companies
 

Industry Analysis

INDR

Industry Average

Valuation INDR Industry Range
Price/Earnings 47.3x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 30.9x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOCO REMEDIES LTD, please visit www.indoco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.